Profil
Xunwei Dong worked as a Medical Director at Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
before becoming the Chief Medical Officer at Kintor Pharmaceutical Ltd.
from 2019 to 2023.
Dr. Dong holds a doctorate degree from Peking Union Medical College.
Anciens postes connus de Xunwei Dong
Sociétés | Poste | Fin |
---|---|---|
KINTOR PHARMACEUTICAL LIMITED | Directeur Technique/Scientifique/R&D | 01/03/2023 |
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Directeur Technique/Scientifique/R&D | - |
Formation de Xunwei Dong
Peking Union Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
KINTOR PHARMACEUTICAL LIMITED | Health Technology |
Entreprise privées | 1 |
---|---|
Ruiibo (Suzhou) Pharmaceutical Co., Ltd.
Ruiibo (Suzhou) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Novartis Pharma Technology Co., Ltd. engages in the production of patented active pharmaceutical ingredients. Its business activities include research and development of patented raw materials, production of dangerous chemicals, and export of products. The company was founded on February 16, 2006 and is headquartered in Changshu, China. | Health Technology |